How the Bombesin Peptide Signals Your Brain to Stop Eating | Research

The takeaway

Mice lacking the gastrin-releasing peptide receptor no longer stop eating when given bombesin, confirming this receptor is key to the peptide's appetite-suppressing effect.

Complete loss
GRP-R knockout mice showed zero feeding suppression from bombesin, while normal mice significantly reduced food intake

What the researchers found

GRP-R knockout mice completely lost bombesin-induced feeding suppression, demonstrating that GRP-R is the key receptor mediating this satiety signal.

Why it matters

Identifying GRP-R as the specific receptor for bombesin's appetite suppression opens the door to developing targeted peptide-based treatments for obesity and eating disorders.

How the study worked

Animal study using GRP-R gene knockout mice. Feeding behavior was measured after bombesin administration and compared between knockout and wild-type controls.

What this study cannot tell us

Animal study in mice; results may not directly translate to humans. Knockout models eliminate the receptor entirely, which is more extreme than pharmacological modulation.

How to read the evidence

Moderate evidence from a well-designed knockout mouse study with clear results, but limited to animal models.

When this study was published

Published in 1998. The GRP receptor system remains an active area of research in appetite regulation.

The bigger picture

Neuropeptides like bombesin play crucial roles in regulating hunger and satiety. Pinpointing which receptor mediates these effects is essential for developing peptide therapies that can precisely target appetite without unwanted side effects.

Questions still open

Could selective GRP-R agonists serve as appetite suppressants in humans?
Are there compensatory mechanisms that develop in GRP-R knockout mice over time?
What role do the other two bombesin receptor subtypes play in feeding behavior?

Common questions

What is bombesin?

Bombesin is a neuropeptide originally found in frog skin that has potent effects on appetite suppression, gut motility, and hormone release in mammals. Related peptides like GRP are found naturally in the human body.

Could bombesin-like peptides be used for weight loss?

This study identifies the specific receptor involved, which is a key step. However, developing a bombesin-based weight loss drug would require human trials and careful management of side effects, since GRP receptors affect multiple body systems.

Read the original research

Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice.

Proceedings of the National Academy of Sciences of the United States of America, 95(6), 3188-92

View on PubMed ↗

Citation

Hampton, L L; Ladenheim, E E; Akeson, M; Way, J M; Weber, H C; Sutliff, V E; Jensen, R T; Wine, L J; Arnheiter, H; Battey, J F. (1998). Loss of bombesin-induced feeding suppression in gastrin-releasing peptide receptor-deficient mice.. Proceedings of the National Academy of Sciences of the United States of America, 95(6), 3188-92.